Long-time cannabis critic says medicine’s growth ‘more concerning’ than opioid epidemic by Martin Lane September 18, 2023September 20, 2023 Long-time medicinal cannabis critic Professor Michael Vagg has claimed the medicine’s growth in Australia is more […]
Bod Science clinical trial ‘proves the efficacy of CBD’ for pharmacy sales by Steve Jones September 6, 2023September 7, 2023
Bod Science eyes new revenue streams after reporting heavy loss by Steve Jones August 30, 2023August 30, 2023
Financial results: Bod Science; Zelira Therapeutics; Emyria; Epsilon Healthcare; Elixinol; MGC Pharma by Steve Jones August 1, 2023April 30, 2024
Study delivers ‘new chapter’ for Bod as Aqua Phase tech shows its worth by Steve Jones July 26, 2023April 30, 2024
Bod plotting ‘immediate’ overseas move if CBD sleep trial succeeds by Steve Jones July 19, 2023April 30, 2024
Bod Science faces nervy wait as final patient completes S3 clinical trial by Steve Jones July 10, 2023April 30, 2024
Bod Science to test drug-delivery tech on psychiatric medication by Steve Jones May 31, 2023April 30, 2024
